Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
06/2007
06/12/2007US7230132 Aryl N-cyanoguanidines and methods related thereto
06/12/2007US7230106 Process for the preparation of inhibitors of macrophage migration inhibitory factor
06/12/2007US7230103 Substituted 3,4-dihydropyrido[1,2-a]pyrimidines
06/12/2007US7230096 derivatives of 3'-amino LacNAc for treatment of inflammation, septic shock, cancer, autoimmune diseases, rheumatoid arthritis and multiple schlerosis
06/12/2007US7230086 Assay for YKL-40 as a marker for degradation of mammalian connective tissue matrices
06/12/2007US7230083 Genetic engineered vitronectin receptors; restenosis therapy, anticancer agents
06/12/2007US7230078 for prophylaxis, prevention, treatment or therapy of inflammatory conditions or allergic reactions in a mammal; binds bacterial lipopeptide
06/12/2007US7230026 Selected fused pyrrolocarbazoles
06/12/2007US7230018 Substituted propane-1,3-diamine derivatives and the pharmaceutical use thereof
06/12/2007US7230017 For therapy of neuroprotective agents in the treatment of neuronal disorders of the central and peripheral nervous systems
06/12/2007US7230015 Potassium/sodium channel blockers; for treatment of multiple sclerosis, spinal cord injury, traumatic brain injury, stroke, bladder irritation and dysfunction, neuropathic pain and chemokine-induced pain
06/12/2007US7230001 Arylalkane, arylalkene and aryl azaalkane, medicaments containing said compounds and method for the production thereof
06/12/2007US7229994 Analgesics; anxiolytic agents; gastrointestinal disorders
06/12/2007US7229987 Oxazoles with one or more tertiary amine groups and phenyl groups, e.g., 1-{4-[2-(Benzofuran-2-ylmethoxymethyl)-oxazol-5-yl]-phenyl}-3-(2-dimethylamino-ethyl)-urea and -(3-{4-[2-(2-Phenoxy-ethylsulfanylmethyl)-oxazol-5-yl]-phenoxy}-propyl)-azepine; treating obesity and related diseases, e.g., diabetes
06/12/2007US7229985 2-(1-isopropoxy-carbonyloxy-2-methylpropyl)-7, 8-dimethoxy-4(5H), 10-dioxo-2H-1,2,3-triazolo[4,5-c][1]benzazepine having a solubility of 15-20 mu g/mL in a 1 wt % methylcellulose solution at 37 degrees and a polymer, especially methylcellulose and/or hydroxypropylmethylcellulose.
06/12/2007US7229962 A fusion protein is dimerized with two soluble extracellular domains of proteins by intermolecular disulfide bonds, formation/s-s/; improved stability and therapeutic effects
06/12/2007US7229809 Use of modified lysozyme c to prepare medicinal compositions for the treatment of some serious diseases
06/12/2007US7229646 Methods and compositions for modulating immune response and for the treatment of inflammatory disease
06/12/2007US7229639 Antiinflammatory agents, analgesics, antiarthritic agents; liquid filled capsulaes
06/12/2007US7229629 Oxidation resistance
06/12/2007CA2392674C Pyrazoloquinolinone derivatives as protein kinase c inhibitors
06/12/2007CA2354023C Phenylglycine derivatives
06/12/2007CA2326510C Dextran formulations and method for treatment of inflammatory joint disorders
06/12/2007CA2248772C Novel peptides which inhibit complement activation
06/12/2007CA2198005C Pyrazolo[3,4-g]quinoxaline compounds which inhibit pdgf receptor protein tyrosine kinase
06/07/2007WO2007065128A2 Human alpha-defensins inhibit interleukin-1beta release
06/07/2007WO2007064993A2 Bicyclic protein kinase inhibitors
06/07/2007WO2007064244A1 Medicinal agent
06/07/2007WO2007063935A1 Aromatic compound
06/07/2007WO2007063934A1 Alicyclic heterocyclic compound
06/07/2007WO2007063925A1 2-aminobenzamide derivative
06/07/2007WO2007063311A2 Competitive domain antibody formats that bind interleukin 1 receptor type 1
06/07/2007WO2007063042A1 R-mirtazapine for the treatment of pain
06/07/2007WO2007063010A1 Novel vinylogous acids derivatives
06/07/2007WO2007062797A1 Amino-substituted azo-heterocyclic compounds for treating inflammatory conditions
06/07/2007WO2007062468A1 Biologically active compounds
06/07/2007WO2007062459A1 Selective kinase inhibitors based on pyridine scaffold
06/07/2007WO2007043710A9 Novel dihydropseudoerythromycin derivatives
06/07/2007WO2007042786A3 4 -heteroaryl pyrimidine derivatives and use thereof as protein kinase inhibitors
06/07/2007WO2007041076A3 1,2,3,5-tetrahydro-cyclopental[c]quinolin-4-one derivatives as rxr agonists for the treatment of dyslipidemia, hypercholesterolemia and diabetes
06/07/2007WO2007031326A3 3-(2-dimethylaminomethyl cyclohexyl) phenol retard formulation
06/07/2007WO2007030940A3 Methods of modulating neurotrophin-mediated activity
06/07/2007WO2007025090A3 Heterobicyclic and - tricyclic inhibitors of mapk/erk kinase
06/07/2007WO2007024949A3 Alpha2c adrenoreceptor agonists
06/07/2007WO2007015877A3 Inhibitors of p38 kinase and methods of treating inflammatory disorders
06/07/2007WO2007012748A3 Novel milk protein fractions and use thereof for preventing or treating chronic inflammatory diseases
06/07/2007WO2006101867A3 Treatment of inflammatory bowel disease
06/07/2007US20070129440 Polypharmacophoric agents
06/07/2007US20070129426 Therapeutic drugs for arthritis
06/07/2007US20070129373 Phthalazinone-piperidino-derivatives as PDE4 inhibitors
06/07/2007US20070129367 Pyridine derivatives as cb2 receptor modulators
06/07/2007US20070129366 Methods for the treatment of chronic pain and compositions therefor
06/07/2007US20070129354 Biphenyl carboxylic amide p38 kinase inhibitors
06/07/2007US20070129316 antidepressant comprising at least one of scymnol or scymnol esters, soybean isoflavones and soybean isoflavone glycosides, curcumin, and or cholic acid; herbal medicine
06/07/2007US20070129285 Protein a compositions and methods of use
06/07/2007US20070128648 Methods for the Identification of IKKalpha Function and other Genes Useful for Treatment of Inflammatory Diseases
06/07/2007US20070128616 Aggrecanase molecules
06/07/2007US20070128603 Diagnostic and therapeutics for diseases associated with 5-hydroxytryptamine (serotonin) receptor 7 (5-ht7)
06/07/2007US20070128276 Controlled release compositions comprising nimesulide
06/07/2007US20070128203 Anti-integrin antibodies, compositions, methods and uses
06/07/2007US20070128178 Probiotics for gut neuromuscular functions
06/07/2007US20070128177 Methods and compositions for lowering the level of tumor necrosis factor (TNF) in TNF-associated disorders
06/07/2007US20070128112 Fully human monoclonal antibodies that inhibit neovascularization of solid tumors; assaying for MCP-1; cancer diagnosis; may be conjugated to a chemotherapeutic agent such as taxol, doxorubicin, cis-platinum, and 5-fluorouracil.
06/07/2007CA2632866A1 Noncompetitive domain antibody formats that bind interleukin 1 receptor type 1
06/07/2007CA2631232A1 Novel vinylogous acids derivatives
06/07/2007CA2631127A1 Biologically active compounds
06/07/2007CA2629964A1 2-aminobenzamide derivative
06/07/2007CA2629850A1 Competitive domain antibody formats that bind interleukin 1 receptor type 1
06/06/2007EP1793006A2 Nucleic acid ligands and improved methods for producing the same
06/06/2007EP1793000A1 Transgenically produced non-secreted proteins
06/06/2007EP1792994A2 Vaccines of bacterial outer membrane vesicles
06/06/2007EP1792910A2 Effectors of dipeptidyl peptidase IV for topical use
06/06/2007EP1792618A1 R-mirtazapine for the treatment of pain
06/06/2007EP1792615A1 Method of screening for a visceral pain inhibitor
06/06/2007EP1792610A2 Sustained release bioadhesive therapeutic systems
06/06/2007EP1791833A2 4-(condensed cyclicmethyl)-imidazole-2-thiones acting as alpha2 adrenergic agonists
06/06/2007EP1791832A1 4-(heteroaryl-methyl and substituted heteroaryl-methyl)-imidazole-2-thiones acting as alpha2 adrenergic agonists
06/06/2007EP1791831A2 Methods of treating diseases and disorders by targeting multiple kinases
06/06/2007EP1791552A2 Protein a compositions and methods of use
06/06/2007EP1496894A4 Angiogenesis inhibitors
06/06/2007EP1489083B1 Fused bicyclic pyridine derivative as tachykinin receptor antagonist
06/06/2007EP1406660B1 Combination of an aldosterone receptor antagonist and an hmg coa reductase inhibitor
06/06/2007EP1395834B1 Screening method which uses bnpi and dnpi
06/06/2007EP1363874B1 Tryptase inhibitors
06/06/2007EP0839039B2 Paroxetine controlled release compositions
06/06/2007CN2907589Y Electric heating plaster contg. traditional Chinese medicine
06/06/2007CN1976937A The extract of bulbophgllum radiatum lindl and the preparation and the use
06/06/2007CN1976931A Beta-carbolines useful for treating inflammatory disease
06/06/2007CN1976918A 4,5-disubstituted-2-aryl pyrimidines
06/06/2007CN1976908A Method for preparing 5-[4-(2-hydroxy-ethyl)-3,5-dioxo-4,5-dihydro-3H-[1,2,4]-triazin-2-yl]benzamide derivatives with P 2 X 7 inhibiting activity by reaction of the derivative unsubstituted in 4-positi
06/06/2007CN1976722A 活性物质联合 Active substances combined
06/06/2007CN1976700A Treatment of neuropathic pain, fibromyalgia or rheumatoid arthritis
06/06/2007CN1976690A Pharmaceutical compositions for the treatment of disease and/or symptoms in arthritis
06/06/2007CN1976682A Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active component
06/06/2007CN1974595A Amino butanetriol aescin and its prepn process
06/06/2007CN1974574A Novel tricyclic spiropiperidines or spiropyrrolidines
06/06/2007CN1974570A Fused pyrrolocarbazoles against inflammation
06/06/2007CN1973893A Externally applied medicine for treating neck and waist arthrosis
06/06/2007CN1973888A Process of extracting rutin and other flavone matters from asparagus
06/06/2007CN1973882A Pain-relieving plaster and its prepn
1 ... 535 536 537 538 539 540 541 542 543 544 545 546 547 548 549 550 551 552 553 554 555 ... 1272